Ivermectin in Clinical Practice

Macrolide Antibiotics: Chemistry, Biology, and Practice: Second Edition

Volumn , Issue , 2003, Pages 403-419

  Zaha, Osamu ^a   Hirata, Tetsuo ^a   Kinjo, Fukunori ^a   Saito, Atsushi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 5444241785     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012526451-8/50009-6     Document Type: Chapter

References (64)

1. Schaeffer J.M., Haines H.W. Avermectin binding in Caenorhabditis elegans: A two-state mode for the avermectin binding site. Biochem. Pharmacol. 1989, 38:2329-2338.
2. Rohrer S.P., Birzin E.T., Eary C.H., Schaeffer J.M., Shoop W.L. Ivermectin binding sites in sensitive and resistant Haemonchus contortus. J. Parasitol. 1994, 80:493-497.
3. Rohrer S.P., Bizin E.T., Costa S.D., Arena J.P., Hayes E.C., Schaeffer J.M. Identification of neuron-specific invermectin binding sites in Drosophila melanogaster and Schistocerca americana. Insect Biochem. Mol. Biol. 1995, 25:11-17.
4. Arena J.P., Liu K.K., Paress P.S., Schaeffer J.M., Cully D.F. Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: Evidence for modulation by avermectin. Mol. Brain Res. 1992, 15:339-348.
5. Cully D.F., Paress P.S., Liu K.K., Schaeffer J.M., Arena J.P. Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin. J. Biol. Chem. 1996, 271:20,187-20,191.
6. World Health Organization Report of a WHO expert committee on onchocerciasis control. Technical Report 852 1995, World Health Organization, Geneva.
7. Taylor H.R., Greene B.M. Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis. Br. J. Ophthalmol. 1981, 65:494-502.
8. Francis H., Awadzi K., Ottesen E.A. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: Clinical severity as a function of infection intensity. Am. J. Trop. Med. Hyg. 1985, 34:529-536.
9. Aziz M.A., Diallo S., Diop I.M., Lariviere M., Porta M., Gaxotte P. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982, 2:171-173.
10. Aziz M.A., Diallo S., Diop I.M., Lariviere M., Porta M., Gaxotte P. Ivermectin in onchocerciasis. Lancet 1982, 2:1456-1457.
11. Taylor H.R., Murphy R.P., Newland H.S., White A.T., D'Anna S.A., Keyvan-Larijani E., Aziz M.A., Cupp E.W., Greene B.M. Comparison of the treatment of ocular onchocerciasis with ivermectin and diethylcarbamazine. Arch. Ophthalmol. 1986, 104:863-870.
12. Dadzie K.Y., Bird A.C., Awadzi K., Schulz-Key H., Gilles H.M., Aziz M.A. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Br. J. Ophthalmol. 1987, 71:78-85.
13. Greene B.M., Taylor H.R., Cupp E.W., Murphy R.P., White A.T., Aziz M.A., Schulz-Key H., D'Anna S.A., Newland H.S., Goldschmidt L.P., Auer C., Hanson A.P., Freeman S.V., Reber E.W., Williams P.N. Comparison of ivermectin and dietylcarbamazine in the treatment of onchocerciasis. N. Engl. J. Med. 1985, 313:133-138.
14. Lariviere M., Vingtain P., Aziz M., Beauvais B., Weimann D., Derouin F., Ginoux J., Schulz-Key H., Gaxotte P., Basset D., Sarfati C. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. Lancet 1985, 2:174-177.
15. Awadzi K., Dadzie K.Y., Schulz-Key H., Haddock D.R., Gilles H.M., Aziz M.A. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Ann. Trop. Med. Parasitol. 1985, 79:63-78.
16. Diallo S., Aziz M.A., Lariviere M., Diallo J.S., Diop-Mar I., N'Dir O., Badiane S., Py D., Schulz-Key H., Gaxotte P., Victorius A. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:927-934.
17. White A.T., Newland H.S., Taylor H.R., Erttmann K.D., Keyvan-Larijani E., Nara A., Aziz M.A., D'Anna S.A., Williams P.N., Greene B.M. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. J. Infect. Dis. Sep. 1987, 156:463-470.
18. Greene B.M., White A.T., Newland H.S., Keyvan-Larijani E., Dukuly Z.D., Gallin M.Y., Aziz M.A., Williams P.N., Taylor H.R. Single dose therapy with ivermectin for onchocerciasis. Trans. Assoc. Am. Physicians 1987, 100:131-138.
19. Newland H.S., White A.T., Greene B.M., D'Anna S.A., Keyvan-Larijani E., Aziz M.A., Williams P.N., Taylor H.R. Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br. J. Ophthalmol. 1988, 72:561-569.
20. Greene B.M., Dukuly Z.D., Munoz B., White A.T., Pacque M., Taylor H.R. A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis. J. Infect. Dis. 1991, 163:376-380.
21. Awadzi K., Dadzie K.Y., Schulz-Key H., Gilles H.M., Fulford A.J., Aziz M.A. The chemotherapy of onchocerciasis XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann. Trop. Med. Parasitol. 1986, 80:433-442.
22. Arakaki T., Hasegawa H., Asato R., Ikeshiro T., Kinjo F., Saito A. A new method to detect Strongyloides stercoralis from human stool. Jpn. J. Trop. Med. Hyg. 1988, 16:11-17.
23. Arakaki T., Iwanaga M., Kinjo F., Saito A., Asato R., Ikeshiro T. Efficacy of agarplate culture in detection of Strongyloides stercoralis infection. J. Parasitol. 1990, 76:425-428.
24. Koga K., Kasuya S., Ohtomo H. How effective is the agar plate method for Strongyloides stercoralis?. J. Parasitol. 1992, 78:155-156.
25. Sato Y., Kobayashi J., Toma H., Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am. J. Trop. Med. Hyg. 1995, 53:248-250.
26. Salazar S.A., Gutierrez C., Berk S.L. Value of the agar plate method for the diagnosis of intestinal strongyloidiasis. Diagn. Microbiol. Infect. Dis. 1995, 23:141-145.
27. Kobayashi J., Hasegawa H., Forli A.A., Nishimura N.F., Yamanaka A., Shimabukuro T., Sato Y. Prevalence of intestinal parasitic infection in five farms in Holambra, Sao Paulo, Brazil. Rev. Inst. Med. Trop. Sao Paulo 1995, 37:13-18.
28. Oyakawa T., Kuniyoshi T., Arakaki T., Higashionna A., Shikiya K., Sakugawa H., Kadena K., Kitsukawa K., Kinjo F., Saito A., Oyadomari Y., Ishihara M., Miyagi M., Morishima A., Kinjo Y., Asato R. New trial with thiabendazole for treatment of human strongyloidiasis. Kansenshogaku Zasshi. 1991, 65:304-310.
29. Franz K.H. Clinical trials with thiabendazole against human strongyloidiasis. Am. J. Trop. Med. Hyg. 1963, 12:211-214.
30. Grove D.I. Treatment of strongyloidiasis with thiabendazole: An analysis of toxicity and effectiveness. Trans. R. Soc. Trop. Med. Hyg. 1982, 76:114-118.
31. Pelletier L.L. Chronic strongyloidiasis in World War II Far East ex-prisoners of war. Am. J. Trop. Med. Hyg. 1984, 33:55-61.
32. Berk S.L., Verghese A., Alvarez S., Hall K., Smith B. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch. Intern. Med. 1987, 147:1257-1261.
33. Beus A. Comparative study of thiabendazole and mebendazole in strongyloidiasis. Lijec. Vjesn. 1989, 111:98-101.
34. Shikiya K., Kuniyoshi T., Higashionna A., Arakaki T., Oyakawa T., Kadena K., Kinjo F., Saito A., Asato R. Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole. Kansenshogaku Zasshi. 1990, 64:1408-1415.
35. Shikiya K., Kuniyoshi T., Uechi H., Oyakawa T., Kinjo F., Saito A., Ikema M., Nakamura H., Yamashiro M., Asato R. Treatment of strongyloidiasis with mebendazole-long-term eradication and new trials. Kansenshogaku Zasshi. 1991, 65:433-441.
36. Shikiya K., Kinjo N., Ikema M., Yamashiro A., Uechi H., Oyakawa T., Kinjo F., Saito A., Nakamura H., Ohwan T., Yamashiro M., Asato R. Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis. Kansenshogaku Zasshi. 1991, 65:681-686.
37. Shikiya K., Zaha O., Niimura S., Ikema M., Nakamura H., Nakayoshi T., Uechi H., Kinjo F., Saito A., Ohwan T., Yamashiro M., Asato R. Long term eradication rate of mebendazole therapy for strongyloidiasis. Kansenshogaku Zasshi. 1992, 66:354-359.
38. Higa F., Kitsukawa K., Gaja M., Tateyama M., Shikiya K., Shigeno Y., Kinjo F., Saito A. Cytotoxicity of mebendazole against established cell lines from the human, rat, and mouse liver. Arch. Toxicol. 1992, 66:224-227.
39. Niimura S., Hirata T., Zaha O., Nakamura H., Kouchi A., Uehara T., Uechi H., Ohshiro J., Shikiya K., Kinjo F., Saito A. Clinical study of albendazole therapy for strongyloidiasis. Kansenshogaku Zasshi. 1992, 66:1231-1235.
40. Pene P., Mojon M., Garin J.P., Coulaud J.P., Rossignol J.F. Albendazole: A new broad spectrum anthelmintic. Double-blind multicenter clinical trial. Am. J. Trop. Med. Hyg. 1982, 31:263-266.
41. Pungpak S., Bunnag D., Chindanond D., Radmoyos B. Albendazole in the treatment of strongyloidiasis. Southeast Asian J. Trop. Med. Public Health 1987, 18:207-210.
42. Naquira C., Jimenez G., Guerra J.G., Bernal R., Nalin D.R., Neu D., Aziz M. Ivermectin for human strongyloidiasis and other intestinal helminths. Am. J. Trop. Med. Hyg. 1989, 40:304-309.
43. Freedman D.O., Zierdt W.S., Lujan A., Nutman T.B. The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. J. Infect. Dis. 1989, 159:1151-1153.
44. Shikiya K., Kinjo N., Uehara T., Uechi H., Ohshiro J., Arakaki T., Kinjo F., Saito A., Iju M., Kobari K. Efficacy of ivermectin against Strongyloides stercoralis in humans. Intern. Med. 1992, 31:310-312.
45. Shikiya K., Uehara T., Uechi H., Ohshiro J., Arakaki T., Oyakawa T., Sakugawa H., Kinjo F., Saito A., Asato R. Clinical study on ivermectin against Strongyloides stercoralis. Kansenshogaku Zasshi. 1991, 65:1085-1090.
46. Shikiya K., Zaha O., Niimura S., Nakamura H., Nakayoshi T., Kochi A., Uehara T., Uechi H., Ohshiro J., Kinjo F., Saito A. Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis. Kansenshogaku Zasshi. 1992, 66:935-943.
47. Shikiya K., Zaha O., Niimura S., Uehara T., Ohshiro J., Kinjo F., Saito A., Asato R. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi. 1994, 68:13-20.
48. Datry A., Hilmarsdottir I., Mayorga-Sagastume R., Lyagoubi M., Gaxotte P., Biligui S., Chodakewitz J., Neu D., Danis M., Gentilini M. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: Results of an open study of 60 cases. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:344-345.
49. Marti H., Haji H.J., Savioli L., Chwaya H.M., Mgeni A.F., Ameir J.S., Hatz C. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am. J. Trop. Med. Hyg. 1996, 55:477-481.
50. Gann P.H., Neva F.A., Gam A.A. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J. Infect. Dis. 1994, 169:1076-1079.
51. Addiss D.G., Beach M.J., Streit T.G., Lutwick S., LeConte F.H., Lafontant J.G., Hightower A.W., Lammie P.J. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 1997, 350:480-484.
52. Ismail M.M., Jayakody R.L., Weil G.J., Nirmalan N., Jayasinghe K.S., Abeyewickrema W., Rezvi Sheriff M.H., Rajaratnam H.N., Amarasekera N., de Silva D.C.L., Michalski M.L., Dissanaike A.S. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:94-97.
53. Glaziou P., Cartel J.L., Alzieu P., Briot C., Moulia-Pelat J.P., Martin P.M. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Trop. Med. Parasitol. 1993, 44:331-332.
54. Macotela-Ruiz E., Pena-Gonzalez G. The treatment of scabies with oral ivermectin. Gac. Med. Mex. 1993, 129:201-205.
55. Kar S.K., Mania J., Patnaik S. The use of ivermectin for scabies. Natl. Med. J. India 1994, 7:15-16.
56. Currie B.J., Connors C.M., Krause V.L. Scabies programs in aboriginal communities. Med. J. Aust. 1994, 161:636-637.
57. Lawrence G.W., Sheridan J.W., Speare R. We can get rid of scabies: New treatment available soon. Med. J. Aust. 1994, 161:232.
58. Marty P., Gari-Toussaint M., Le Fichoux Y., Gaxotte P. Efficacy of ivermectin in the treatment of an epidemic of sarcoptic scabies. Ann. Trop. Med. Parasitol. 1994, 88:453.
59. Meinking T.L., Taplin D., Hermida J.L., Pardo R., Kerdel F.A. The treatment of scabies with ivermectin. N. Engl. J. Med. 1995, 333:26-30.
60. Youssef M.Y., Sadaka H.A., Eissa M.M., el-Ariny A.F. Topical application of ivermectin for human ectoparasites. Am. J. Trop. Med. Hyg. 1995, 53:652-653.
61. Currie B.J., Maguire G.P., Woodm Y.K. Ivermectin and crusted (Norwegian) scabies. Med. J. Aust. 1995, 163:559-560.
62. Aubin F., Humbert P. Ivermectin for crusted (Norwegian) scabies. N. Engl. J. Med. 1995, 332:612.
63. Saito A. Strongyloidiasis: Epidemiology, clinical manifestation and new methods for diagnosis and treatment. J. Infect. Chemother. 1995, 1:98-106.
64. Zaha O., Hirata T., Kinjo F., Saito A. Strongyloidiasis: Progress in diagnosis and treatment. Intern. Med. 2000, 39:695-700.